V-domain Ig suppressor of T cell activation (VISTA) inhibition is a new approach to cancer therapy: a Bibliometric study

• Published in: Naunyn-Schmiedeberg's archives of pharmacology 2021-06, Vol.394 (6), p.1057-1065
• Main Author: Ait Boujmia, Oum Kaltoum
• Format: Article
• Language: English
• Subjects: Animals; B7 Antigens - antagonists & inhibitors; Bibliometrics; Biomedical and Life Sciences; Biomedicine; Cancer; Cancer research; Cancer therapies; Cell activation; Humans; Immunoglobulins; Immunology; Immunotherapy; Immunotherapy - methods; Journal Impact Factor; Literature reviews; Lymphocytes T; Medical research; Mice; Neoplasms - immunology; Neoplasms - therapy; Neurosciences; Periodicals as Topic - statistics & numerical data; Pharmacology/Toxicology; Review Article
• ISSN: 0028-1298; 1432-1912
• DOI: 10.1007/s00210-021-02068-4

V-domain Ig suppressor of T cell activation (VISTA) is a transmembrane protein that plays a crucial role in the regulation of antitumor immunity. Therapeutic intervention that inhibits the VISTA pathway constitutes a new approach in the treatment of cancer. The aim of the present study was to provide a bibliometric literature review of VISTA research in the field of cancer. Published articles on the topic were retrieved from the Web of Science Core Collection Database of Hassan II University from the beginning of the database to November 14, 2019. The articles were analyzed and a lot of information was available on the Web of Science, such as the number of citations, the names of the authors, country, publication year, Web of Science categories, and journal. A total of 76 papers (research and review articles) were retrieved from the Web of Science Core Collection Database to introduce VISTA research in cancer topic. All of the articles were published in English during the period between 2011 and 2019; the annual publications number has increased from 1 in 2011 to 22 in 2019. Cancer immunology immunotherapy journal, Cancer immunology research journal, and Cancer research journal, each one has published 3 articles (3.9% of the total publications), the impact factors of the journals ranged from 2.34 to 10.19. The author who has published high number of articles was Noelle RJ with 11 articles; according to the keyword co-occurrence, VISTA was the most frequent keyword with a frequency of 42.1%, followed by immune (36.8%). This is the first work that treats the application of bibliometric methods in VISTA research in the oncology field and represents an important bibliographic source for future studies on the role of VISTA in cancer and immunotherapy of cancer.